1. Zarate, Yuri A, Bosanko, Katherine A, Caffrey, Aisling R, Gavrilova, Ralitza, Fish, Jennifer L. 2019. Mutation update for the SATB2 gene. In Human mutation, 40, 1013-1029. doi:10.1002/humu.23771. https://pubmed.ncbi.nlm.nih.gov/31021519/
2. Wahl, Nico, Espeso-Gil, Sergio, Chietera, Paola, Dechant, Georg, Apostolova, Galina. 2024. SATB2 organizes the 3D genome architecture of cognition in cortical neurons. In Molecular cell, 84, 621-639.e9. doi:10.1016/j.molcel.2023.12.024. https://pubmed.ncbi.nlm.nih.gov/38244545/
3. Ma, Yang, Liu, Hangyu, Shi, Lungang. 2023. Progress of epigenetic modification of SATB2 gene in the pathogenesis of non-syndromic cleft lip and palate. In Asian journal of surgery, 47, 72-76. doi:10.1016/j.asjsur.2023.09.113. https://pubmed.ncbi.nlm.nih.gov/37852859/
4. Chen, Qiao Yi, Des Marais, Thomas, Costa, Max. . Deregulation of SATB2 in carcinogenesis with emphasis on miRNA-mediated control. In Carcinogenesis, 40, 393-402. doi:10.1093/carcin/bgz020. https://pubmed.ncbi.nlm.nih.gov/30916759/
5. Zarate, Yuri A, Fish, Jennifer L. 2016. SATB2-associated syndrome: Mechanisms, phenotype, and practical recommendations. In American journal of medical genetics. Part A, 173, 327-337. doi:10.1002/ajmg.a.38022. https://pubmed.ncbi.nlm.nih.gov/27774744/
6. Roy, Sanjit K, Shrivastava, Anju, Srivastav, Sudesh, Shankar, Sharmila, Srivastava, Rakesh K. 2020. SATB2 is a novel biomarker and therapeutic target for cancer. In Journal of cellular and molecular medicine, 24, 11064-11069. doi:10.1111/jcmm.15755. https://pubmed.ncbi.nlm.nih.gov/32885593/
7. Gurramkonda, Venkatesh Babu, Syed, Altaf Hussain, Murthy, Jyotsna, Lakkakula, Bhaskar V K S. 2015. SATB2 gene variants in non-syndromic cleft lip with or without cleft palate in Indian population. In Journal of oral biology and craniofacial research, 5, 161-4. doi:10.1016/j.jobcr.2015.06.014. https://pubmed.ncbi.nlm.nih.gov/26605140/
8. Jin, Juan, Chen, Fen, He, Wenfang, He, Hongchao, He, Qiang. . YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma. In Cancer research, 83, 786-803. doi:10.1158/0008-5472.CAN-22-1693. https://pubmed.ncbi.nlm.nih.gov/36598364/
9. Cleven, Arjen H G, Szuhai, Karoly, van IJzendoorn, David G P, Baumhoer, Daniel, Bovée, Judith V M G. . Psammomatoid Ossifying Fibroma Is Defined by SATB2 Rearrangement. In Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 36, 100013. doi:10.1016/j.modpat.2022.100013. https://pubmed.ncbi.nlm.nih.gov/36788065/
智鼠故事 
